Experimental weight-loss drug from a small biotech could outdo Ozempic

Viking Therapeutics posted results of an experimental drug that showed even better weight loss than the current market-leading drugs, a sign that the dominance of Ozempic and Mounjaro is far from assured. Get a curated selection of 10 of our best stories in your inbox every weekend. Viking said…#mounjaro #obese #elilillys #novonordisks #elililly #davidrisinger #leerinkpartners #novonordisk #novonordisksozempic #brianlian
Source: Reuters: Health - Category: Consumer Health News Source Type: news